Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Andrews

Showing results (61-70 of 368) with videos related to

Pageof 37
Sort By:
The Journal of Antimicrobial Chemotherapy|October 26, 2012
BSAC standardized disc susceptibility testing method (version 11)R A Howe, J M Andrews,
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 1, 1973
The significance of dense core particles in subacute demyelinating disease in an adultJ M Andrews, R L Andrews
Bulletin of the Los Angeles Neurological Societies|October 1, 1971
Basic concepts of ultrastructural neuroanatomyJ M Andrews, R L Vernand
Antimicrobial Agents and Chemotherapy|March 1, 1982
In vitro activity of cefotetan, a new cephamycin derivative, compared with that of other beta-lactam compoundsR Wise, J M Andrews, J Hancox
The Journal of Antimicrobial Chemotherapy|May 1, 1981
N-formimidoyl-thienamycin a novel beta-lactam: an in-vitro comparison with other beta-lactam antibioticsR Wise, J M Andrews, N Patel
The Journal of Antimicrobial Chemotherapy|January 1, 1996
A survey of antimicrobial susceptibility testing in the United KingdomJ M Andrews, D Brown, R Wise
The Journal of Antimicrobial Chemotherapy|April 1, 1993
The in-vitro activity of OPC-17116, a new 5-methyl substituted quinoloneR Wise, J M Andrews, N Brenwald
Antimicrobial Agents and Chemotherapy|March 19, 2002
In vitro activities of peptide deformylase inhibitors against gram-positive pathogensR Wise, J M Andrews, J Ashby
The Journal of Antimicrobial Chemotherapy|May 1, 1981
6-beta-bromo- and 6-beta-iodo penicillanic acid, two novel beta-lactamase inhibitorsR Wise, J M Andrews, N Patel
Reviews of Infectious Diseases|January 1, 1988
Pharmacokinetics of the quinolones in volunteers: a proposed dosing scheduleR Wise, D Griggs, J M Andrews
Pageof 37

Showing results (61-70 of 368) with videos related to

Sort By:
Pageof 37
The Journal of Antimicrobial Chemotherapy|October 26, 2012
BSAC standardized disc susceptibility testing method (version 11)R A Howe, J M Andrews,
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 1, 1973
The significance of dense core particles in subacute demyelinating disease in an adultJ M Andrews, R L Andrews
Bulletin of the Los Angeles Neurological Societies|October 1, 1971
Basic concepts of ultrastructural neuroanatomyJ M Andrews, R L Vernand
Antimicrobial Agents and Chemotherapy|March 1, 1982
In vitro activity of cefotetan, a new cephamycin derivative, compared with that of other beta-lactam compoundsR Wise, J M Andrews, J Hancox
The Journal of Antimicrobial Chemotherapy|May 1, 1981
N-formimidoyl-thienamycin a novel beta-lactam: an in-vitro comparison with other beta-lactam antibioticsR Wise, J M Andrews, N Patel
The Journal of Antimicrobial Chemotherapy|January 1, 1996
A survey of antimicrobial susceptibility testing in the United KingdomJ M Andrews, D Brown, R Wise
The Journal of Antimicrobial Chemotherapy|April 1, 1993
The in-vitro activity of OPC-17116, a new 5-methyl substituted quinoloneR Wise, J M Andrews, N Brenwald
Antimicrobial Agents and Chemotherapy|March 19, 2002
In vitro activities of peptide deformylase inhibitors against gram-positive pathogensR Wise, J M Andrews, J Ashby
The Journal of Antimicrobial Chemotherapy|May 1, 1981
6-beta-bromo- and 6-beta-iodo penicillanic acid, two novel beta-lactamase inhibitorsR Wise, J M Andrews, N Patel
Reviews of Infectious Diseases|January 1, 1988
Pharmacokinetics of the quinolones in volunteers: a proposed dosing scheduleR Wise, D Griggs, J M Andrews
Pageof 37